65.07%Interest Expense Margin

VS

Market

3

Sector

8

Industry

13

History

35

$ 4.08Close

$ 1.1 - $ 4.61 52-Week Range

Ticker Information

Ticker

ADCT

Company Name

ADC THERAPEUTICS SA

Sector

Healthcare

Industry

Biotechnology

Exchange

NYSE

ADC THERAPEUTICS SA - Interest Expense Margin Chart Analysis (TTM)

From

Zoom

1Y

3Y

5Y

10Y

ADCT - Int. Exp. % Historical data

Date	Interest Expense	Interest Expense Margin	Revenues
6/30/2025	$ 50.26M	65.07%	$ 77.25M
3/31/2025	$ 49.95M	65.88%	$ 75.82M
12/31/2024	$ 50.21M	70.88%	$ 70.84M
9/30/2024	$ 45.97M	65%	$ 70.72M
6/30/2024	$ 45.79M	68.61%	$ 66.75M
3/31/2024	$ 48.97M	71.37%	$ 68.62M
12/31/2023	$ 46.33M	66.6%	$ 69.56M
9/30/2023	$ 46.77M	38.16%	$ 122.57M
6/30/2023	$ 45.18M	24.5%	$ 184.39M
3/31/2023	$ 38.12M	20.9%	$ 182.4M

1

Key Performance Insights, Last 5 Years

ADC THERAPEUTICS SA's latest trailing twelve months (TTM) Int. Exp. % stands at 0%.
Over the past 5 years, ADC THERAPEUTICS SA's average Int. Exp. % has been 59.44%.
The median Int. Exp. % for ADC THERAPEUTICS SA during this period was 64.28%
ADC THERAPEUTICS SA reached its highest Int. Exp. % over the past 5 years at 227.18%.
The lowest Int. Exp. % recorded by ADC THERAPEUTICS SA in the same timeframe 17.59%

ADC THERAPEUTICS SA's Int. Exp. % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Int. Exp. % Benchmarks

Company	Int. Exp. %
YMAB : Y-MABS THERAPEUTICS INC	-4.72%	TRDA : ENTRADA THERAPEUTICS INC	0%	NKTR : NEKTAR THERAPEUTICS	35.42%	CDXS : CODEXIS INC	18.93%	LXRX : LEXICON PHARMACEUTICALS INC	21.52%	SCPH : SCPHARMACEUTICALS INC	12.25%	XOMA : XOMA ROYALTY CORP	30.23%	ALEC : ALECTOR INC	0%	SGMO : SANGAMO THERAPEUTICS INC	0%	KURA : KURA ONCOLOGY INC	1.91%

Similar metrics to Revenues:

Definition of Interest Expense Margin

[Calculation] The company’s interest expenses [IntExp] expressed as a percentage of [Revenue].

Int. Exp. / Revenues
 (=) Int. Exp. %

Int. Exp. % for ADC THERAPEUTICS SA is calculated as follows:

Int. Exp. [ $ 4.93M ] / Revenues [ $ 0 ]
 (=) Int. Exp. % [ 0% ]

ADCT - Interest Expense Margin, Last 5 years

17.59%

Minimum

Dec 31, 2022

227.18%

Maximum

Jun 30, 2021

59.44%

Average

64.28%

Median

Int. Exp. % Benchmark Analysis
Market

The chart above depicts the distribution of Int. Exp. % for companies in the Total Stock Market. The average Int. Exp. % of the companies is 1.63% with a standard deviation of 2.2%.

The following table provides additional summary stats:

Int. Exp. % in the Market:

filtered constituents	3.15K
min	-4.94%
max	8.49%
average	1.63%
median	0.79%
std	2.2%

Select company

Select metric

Ticker Information

ADC THERAPEUTICS SA - Interest Expense Margin Chart Analysis (TTM)

From

Zoom

ADCT - Int. Exp. % Historical data

Key Performance Insights, Last 5 Years

ADC THERAPEUTICS SA's Int. Exp. % vs. competitors

Int. Exp. % Benchmarks

Similar metrics to Revenues:

Definition of Interest Expense Margin

ADCT - Interest Expense Margin, Last 5 years

Int. Exp. % Benchmark Analysis
Market

Int. Exp. % in the Market:

Pick a watchlist

Select company

Select metric

Ticker Information

ADC THERAPEUTICS SA - Interest Expense Margin Chart Analysis (TTM)

From

Zoom

ADCT - Int. Exp. % Historical data

Key Performance Insights, Last 5 Years

ADC THERAPEUTICS SA's Int. Exp. % vs. competitors

Int. Exp. % Benchmarks

Similar metrics to Revenues:

Definition of Interest Expense Margin

ADCT - Interest Expense Margin, Last 5 years

Int. Exp. % Benchmark AnalysisMarket

Int. Exp. % in the Market:

Int. Exp. % Benchmark Analysis
Market